These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 4204355

  • 1. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
    Glatzel J.
    Med Welt; 1973 Dec 21; 24(51):2044-6. PubMed ID: 4204355
    [No Abstract] [Full Text] [Related]

  • 2. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ.
    Psychiatr Neurol Neurochir; 1973 Dec 21; 76(2):83-92. PubMed ID: 4573494
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
    Floru L, Zurborn R.
    Med Welt; 1973 Apr 13; 24(15):600-3. PubMed ID: 4744987
    [No Abstract] [Full Text] [Related]

  • 6. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G, Nosè F.
    Minerva Med; 1971 Dec 26; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract] [Full Text] [Related]

  • 7. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic.
    Van Lommel R, Baro F, Dom R.
    Arzneimittelforschung; 1974 Jul 26; 24(7):1072-4. PubMed ID: 4605278
    [No Abstract] [Full Text] [Related]

  • 8. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    Bruck J, Guss H.
    Int Pharmacopsychiatry; 1974 Jul 26; 9(3):152-65. PubMed ID: 4154320
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ, Vereecken JL.
    Acta Psychiatr Scand; 1974 Jul 26; 50(3):346-53. PubMed ID: 4609288
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY, Kurland AA, Slotnick VB.
    J Clin Pharmacol; 1974 Apr 26; 14(4):202-9. PubMed ID: 4595986
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J, Woggon B.
    Arzneimittelforschung; 1975 Feb 26; 25(2):267-70. PubMed ID: 1091272
    [Abstract] [Full Text] [Related]

  • 13. [Long term treatment of schizophrenia with penfluridol].
    Haring C.
    Med Welt; 1977 Apr 01; 28(13):639-42. PubMed ID: 404499
    [No Abstract] [Full Text] [Related]

  • 14. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
    White AC, Sims AC.
    Curr Med Res Opin; 1974 Apr 01; 2(1):23-6. PubMed ID: 4841811
    [No Abstract] [Full Text] [Related]

  • 15. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM, Mielke DH, Spirtes MA, Swanson WC, Bost R.
    Am J Psychiatry; 1974 Jun 01; 131(6):699-702. PubMed ID: 4597305
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].
    Mormont C.
    Acta Psychiatr Belg; 1972 Sep 01; 72(5):595-601. PubMed ID: 4669431
    [No Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
    Zwanikken GJ, Remans B, Dewulf P, Amery W.
    Acta Psychiatr Scand; 1971 Sep 01; 47(3):334-48. PubMed ID: 4946910
    [No Abstract] [Full Text] [Related]

  • 19. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
    Itil T, Gannon P, Cora R, Polvan N, Akpinar S, Elveris F, Eskazan E.
    Behav Neuropsychiatry; 1972 Sep 01; 4(4-5):15-24. PubMed ID: 4566673
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.